PHARMA CRUSADERS: December 2013

Tuesday, 31 December 2013

Drug Patent Expirations for the week of December 29, 2013

Tradename	Applicant	Generic Name	Patent No.
EPIVIR-HBV	Glaxosmithkline	lamivudine	RE39155*PED
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Drug Patent Expirations for the week of December 22, 2013

Tradename	Applicant	Generic Name	Patent No.
DDAVP (NEEDS NO REFRIGERATION)	Sanofi Aventis Us	desmopressin acetate	5,674,850
DDAVP	Sanofi Aventis Us	desmopressin acetate	5,674,850
ANTHELIOS SX	Loreal Usa	avobenzone; ecamsule; octocrylene	5,587,150
VIOXX	Merck	rofecoxib	6,239,173*PED
VIOXX	Merck	rofecoxib	5,474,995*PED
EFFEXOR XR	Wyeth Pharms Inc	venlafaxine hydrochloride	5,916,923*PED
EFFEXOR XR	Wyeth Pharms Inc	venlafaxine hydrochloride	6,444,708*PED
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Tradename	Applicant	Generic Name	Patent No.
EMADINE	Alcon	emedastine difumarate	5,441,958
ENTEREG	Cubist Pharms	alvimopan	5,434,171
EDARBI	Arbor Pharms Llc	azilsartan kamedoxomil	5,583,141
SOLAGE	Aqua Pharms	mequinol; tretinoin	5,194,247
EDARBYCLOR	Arbor Pharms Llc	azilsartan kamedoxomil; chlorthalidone	5,583,141
CYMBALTA	Lilly	duloxetine hydrochloride	5,023,269*PED
ABREVA	Glaxosmithkline	docosanol	5,534,554
LUPRON DEPOT-PED	Abbvie Endocrine Inc	leuprolide acetate	6,036,976
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

PHARMA CRUSADERS: New Trends In Pharmaceutical Sciences (NTPS): NEW TRENDS IN PHARMACEUTICAL SCIENCES (NTPS) EDITORIAL BOARD REGISTER WITH THIS JOURNAL GO TO SUBMISSION PAGE DO...